DeepScan Diagnostics Overview
- Year Founded
-
2022
- Status
-
Private
- Employees
-
12
- Latest Deal Type
-
Series 2
- Latest Deal Amount
-
$3.5M
- Investors
-
4
DeepScan Diagnostics General Information
Description
Operator of a precision veterinary diagnostics platform intended to support early disease detection and ongoing health monitoring in dogs. The company offers blood-based cell-free DNA biomarker testing and canine health data analysis to detect signs of cancer, inflammation, and organ damage, enabling veterinarians and pet owners to identify potential health conditions earlier and make informed treatment decisions.
Contact Information
Website
www.deepscandx.comCorporate Office
- Elimäenkatu 17-19
- 00510 Helsinki
- Finland
Corporate Office
- Elimäenkatu 17-19
- 00510 Helsinki
- Finland
DeepScan Diagnostics Timeline
DeepScan Diagnostics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Early Stage VC (Series 2) | 22-Apr-2026 | $3.5M | Completed | Generating Revenue | ||
| 3. Early Stage VC | 28-Oct-2025 | Completed | Generating Revenue | |||
| 2. Early Stage VC (Series 1) | 19-Nov-2024 | $2.15M | $2.15M | Completed | Generating Revenue | |
| 1. Grant | 07-Feb-2024 | $16.3K | Completed | Generating Revenue |
DeepScan Diagnostics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series 2 Preferred Shares | ||||||||
| Seed Shares |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
DeepScan Diagnostics Patents
DeepScan Diagnostics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20260265830-A1 | Method of measuring cell-free dna in blood of canis familiaris | Pending | 04-Mar-2025 | ||
| JP-2025160560-A | Biological state estimation system, biological state estimation method, program, and recording medium | Pending | 10-Apr-2024 |
DeepScan Diagnostics Signals
DeepScan Diagnostics Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Harjavalta | Family Office | Minority | ||
| Business Finland | Government | Minority | ||
| Calm/Storm Ventures | Venture Capital | Minority | ||
| Runar Bäckström Foundation | Limited Partner |
DeepScan Diagnostics FAQs
-
When was DeepScan Diagnostics founded?
DeepScan Diagnostics was founded in 2022.
-
Where is DeepScan Diagnostics headquartered?
DeepScan Diagnostics is headquartered in Helsinki, Finland.
-
What is the size of DeepScan Diagnostics?
DeepScan Diagnostics has 12 total employees.
-
What industry is DeepScan Diagnostics in?
DeepScan Diagnostics’s primary industry is Other Services (B2C Non-Financial).
-
Is DeepScan Diagnostics a private or public company?
DeepScan Diagnostics is a Private company.
-
What is DeepScan Diagnostics’s current revenue?
The current revenue for DeepScan Diagnostics is .
-
How much funding has DeepScan Diagnostics raised over time?
DeepScan Diagnostics has raised $7.71M.
-
Who are DeepScan Diagnostics’s investors?
Harjavalta, Business Finland, Calm/Storm Ventures, and Runar Bäckström Foundation have invested in DeepScan Diagnostics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process